[go: up one dir, main page]

IT8647936A0 - Composizioni di fenitoina per sommi nistrazione parenterale e procedimento di preparazione - Google Patents

Composizioni di fenitoina per sommi nistrazione parenterale e procedimento di preparazione

Info

Publication number
IT8647936A0
IT8647936A0 IT8647936A IT4793686A IT8647936A0 IT 8647936 A0 IT8647936 A0 IT 8647936A0 IT 8647936 A IT8647936 A IT 8647936A IT 4793686 A IT4793686 A IT 4793686A IT 8647936 A0 IT8647936 A0 IT 8647936A0
Authority
IT
Italy
Prior art keywords
instration
phenytoin
parenteral
compositions
preparation procedure
Prior art date
Application number
IT8647936A
Other languages
English (en)
Other versions
IT1190282B (it
Inventor
Mahdi B Fawzi
Anne K Taylor
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of IT8647936A0 publication Critical patent/IT8647936A0/it
Application granted granted Critical
Publication of IT1190282B publication Critical patent/IT1190282B/it

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IT47936/86A 1985-05-20 1986-04-24 Composizioni di fenitoina per somministrazione parenterale e procedimento di preparazione IT1190282B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/735,932 US4642316A (en) 1985-05-20 1985-05-20 Parenteral phenytoin preparations

Publications (2)

Publication Number Publication Date
IT8647936A0 true IT8647936A0 (it) 1986-04-24
IT1190282B IT1190282B (it) 1988-02-16

Family

ID=24957819

Family Applications (1)

Application Number Title Priority Date Filing Date
IT47936/86A IT1190282B (it) 1985-05-20 1986-04-24 Composizioni di fenitoina per somministrazione parenterale e procedimento di preparazione

Country Status (18)

Country Link
US (1) US4642316A (it)
JP (1) JPS61268618A (it)
AU (1) AU595790B2 (it)
BE (1) BE904476A (it)
CA (1) CA1268119A (it)
CH (1) CH668594A5 (it)
DE (1) DE3610330A1 (it)
DK (1) DK100786A (it)
ES (1) ES8707195A1 (it)
FR (1) FR2581871B1 (it)
GB (1) GB2175203B (it)
IT (1) IT1190282B (it)
LU (1) LU86383A1 (it)
NL (1) NL8600899A (it)
NZ (1) NZ215783A (it)
PH (1) PH22922A (it)
SE (1) SE8600998L (it)
ZA (1) ZA862094B (it)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3828156A1 (de) * 1988-08-19 1990-02-22 Astrapin Pharmazeutische Praep Stabile waessrige loesung von fluorouracil
WO1999004798A1 (en) * 1997-07-22 1999-02-04 Warner-Lambert Company Lyophilized fosphenytoin sodium for parenteral use
WO1999048876A1 (en) 1998-03-20 1999-09-30 Warner-Lambert Company Crystalline sodium phenytoin monohydrate
US6274168B1 (en) 1999-02-23 2001-08-14 Mylan Pharmaceuticals Inc. Phenytoin sodium pharmaceutical compositions
AU2003288588A1 (en) * 2002-12-16 2004-07-09 Ranbaxy Laboratories Limited An extended release pharmaceutical composition of phenytoin sodium
NZ599464A (en) 2005-02-03 2014-03-28 Topotarget Uk Ltd Combination therapies using hdac inhibitors
DE102005019393A1 (de) * 2005-04-25 2006-10-26 Basell Polyolefine Gmbh Polyethylenformmassen für Spritzgussanwendungen
ES2380887T3 (es) 2005-05-13 2012-05-21 Topotarget Uk Limited Formulaciones farmacéuticas de inhibidores de la HDAC
AU2012213940B2 (en) * 2005-05-13 2015-03-26 Topotarget Uk Limited Pharmaceutical formulations of HDAC inhibitors
EP1957056A2 (en) * 2005-11-10 2008-08-20 TopoTarget UK Limited Histone deacetylase (hdac) inhibitors (pxdlol) for the treatment of cancer alone or in combination with chemotherapeutic agent
US8377979B2 (en) * 2005-12-05 2013-02-19 Taro Pharmaceuticals North America, Inc. Pharmaceutical formulation containing phenytoin sodium and magnesium stearate
CA2700173C (en) * 2007-09-25 2016-10-11 Topotarget Uk Limited Methods of synthesis of certain hydroxamic acid compounds
PL2262493T3 (pl) * 2008-03-07 2015-08-31 Onxeo Dk Branch Of Onxeo S A France Sposoby leczenia wykorzystujące wydłużony ciągły wlew belinostatu
GB0900555D0 (en) * 2009-01-14 2009-02-11 Topotarget As New methods
EP3777839A1 (en) 2009-05-19 2021-02-17 Neuroderm Ltd Compositions for continuous administration of dopa decarboxylase inhibitors
SI2640358T1 (en) 2010-11-15 2018-05-31 Neuroderm Ltd. Continuous administration of L-dopa, dopamine decarboxylase inhibitors, catechol-O-methyl transferase inhibitors, and compositions thereof
US9540330B2 (en) 2010-12-15 2017-01-10 Nektar Therapeutics Oligomer-containing hydantoin compounds
MX2014014902A (es) 2012-06-05 2015-03-04 Neuroderm Ltd Composiciones que comprenden apomorfina y acidos organicos y usos de las mismas.
CN106413754B (zh) 2014-03-13 2019-11-29 纽罗德姆有限公司 多巴脱羧酶抑制剂组合物
US10258585B2 (en) 2014-03-13 2019-04-16 Neuroderm, Ltd. DOPA decarboxylase inhibitor compositions
US11213502B1 (en) 2020-11-17 2022-01-04 Neuroderm, Ltd. Method for treatment of parkinson's disease
US11844754B2 (en) 2020-11-17 2023-12-19 Neuroderm, Ltd. Methods for treatment of Parkinson's disease
US11331293B1 (en) 2020-11-17 2022-05-17 Neuroderm, Ltd. Method for treatment of Parkinson's disease
WO2023205615A1 (en) * 2022-04-18 2023-10-26 ISHA Therapeutics LLC Orally dissolving antimicrobial film compositions & methods of their use
US12109303B2 (en) 2022-04-18 2024-10-08 ISHA Therapeutics LLC Orally dissolving antimicrobial film compositions and methods of their use
US12161612B2 (en) 2023-04-14 2024-12-10 Neuroderm, Ltd. Methods and compositions for reducing symptoms of Parkinson's disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3749779A (en) * 1970-08-27 1973-07-31 American Home Prod Stable solutions of sodium diphenylhydantoin
JPS5221575B2 (it) * 1972-03-18 1977-06-11
US4163058A (en) * 1977-04-22 1979-07-31 Interx Research Corporation Derivatives of 5,5-diphenylhydantoin exhibiting enhanced solubility and the therapeutic use thereof
US4260769A (en) * 1977-04-22 1981-04-07 Interx Research Corporation 5,5-Diphenylhydantoins

Also Published As

Publication number Publication date
DK100786D0 (da) 1986-03-05
FR2581871B1 (fr) 1990-05-11
DK100786A (da) 1986-11-21
SE8600998D0 (sv) 1986-03-05
SE8600998L (sv) 1986-11-21
ZA862094B (en) 1986-11-26
CA1268119A (en) 1990-04-24
NL8600899A (nl) 1986-12-16
US4642316A (en) 1987-02-10
DE3610330A1 (de) 1986-11-20
NZ215783A (en) 1989-01-27
GB2175203B (en) 1988-09-14
GB8607383D0 (en) 1986-04-30
ES8707195A1 (es) 1987-07-16
AU5441286A (en) 1986-11-27
JPS61268618A (ja) 1986-11-28
BE904476A (fr) 1986-09-24
GB2175203A (en) 1986-11-26
IT1190282B (it) 1988-02-16
LU86383A1 (fr) 1986-09-02
AU595790B2 (en) 1990-04-12
CH668594A5 (fr) 1989-01-13
ES555143A0 (es) 1987-07-16
PH22922A (en) 1989-01-24
FR2581871A1 (fr) 1986-11-21

Similar Documents

Publication Publication Date Title
IT8647936A0 (it) Composizioni di fenitoina per sommi nistrazione parenterale e procedimento di preparazione
ES2015535B3 (es) Composiciones detergentes, componentes de estas, y procedimientos para su preparacion
IT1191633B (it) Procedimento per la preparazione di (2,2)-paraciclofani alogenati e miscele di (2,2)-paraciclofani alogenati ottenuti
IT1200085B (it) Procedimento per la preparazione di xantoni e di tioxantoni
IT1186761B (it) Procedimento di preparazione di microlattici invertiti ed i microlattici invertiti ottenuti
IT1208807B (it) Derivati di 1 3 ossazolidin 2 one e procedimenti per la loro preparazione
IT8567535A0 (it) Procedimento per la preparazione di amminoidrossicefamcarbossilati
PT84184A (pt) Process for the preparation of 8 alpha-acylaminoergolines and of pharmaceutical compositions containing them
DK396986D0 (da) Parenterale phenytoin-praeparater
IT1197811B (it) 2h-benzotriazoli 5-superiore alchil-sostituiti e composizioni stabilizzate
IT1214726B (it) Derivati di glucosilmoranolina eprocedimento per la loro preparazione
IT1222755B (it) Procedimento per la preparazione di idantoine 5-ariliden e alchiliden sostituite
TR24449A (tr) Tiyazinol tuerevleri hazirlanmalarina mahsus usul v ve fungusid olarak kullanimi
IT1231426B (it) Preparazione di polifluoroenolati
BR8504188A (pt) Preparacao de terpinen-4-ois
IT1200461B (it) Composizioni di farmaci e procedimento per la loro preparazione
IT1203501B (it) Procedimento per la preparazione di encainide
IT8822858A0 (it) Composizioni per la riduzione di flebectasie e procedimento per la loro preparazione
IT1178790B (it) Procedimento di preparazione di miscele carbone-acqua
IT8567781A0 (it) Procedimento di preparazione di cefem derivati
IT8519620A0 (it) Procedimento per la preparazione di amidinouree e composizioni farmaceutiche che le contengono
IT1204839B (it) Composizioni farmaceutiche contenenti vinburnina e loro procedimento di preparazione
RO91930A2 (ro) Procedeu pentru prepararea butirolactonei
RO93344A2 (ro) Procedeu pentru prepararea dodecilfenolului
IT8520828V0 (it) Struttura di passaverdura perfezionato